Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
08/2002
08/27/2002CA2101548C Acylamino-alkylidenhydroxy-bisphosphonic acids useful in the therapy of osteoarticular diseases
08/22/2002WO2002064792A2 Molecules for disease detection and treatment
08/22/2002WO2002064769A1 Novel disease marker
08/22/2002WO2002064748A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
08/22/2002WO2002064634A2 Human monoclonal antibodies to fc alpha receptor (cd89)
08/22/2002WO2002064625A1 Matrix gene expression in chondrogenesis
08/22/2002WO2002064606A1 Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof
08/22/2002WO2002064599A1 Bicyclic pyrimidine matrix metalloproteinase inhibitors
08/22/2002WO2002064598A1 Thieno'2,3-d pyrimidindione derivatives as matrix metalloproteinase inhibitors
08/22/2002WO2002064595A1 Triazolo compounds as mmp inhibitors
08/22/2002WO2002064594A2 6-substituted pyrido-pyrimidines
08/22/2002WO2002064592A1 Tricyclic crf receptor antagonists
08/22/2002WO2002064591A2 Carboline derivatives
08/22/2002WO2002064590A2 Carboline derivatives
08/22/2002WO2002064589A1 Laulimalide derivatives
08/22/2002WO2002064586A2 Heterocyclic inhibitors of erk2 and uses thereof
08/22/2002WO2002064578A1 Benzo thiadiazine matrix metalloproteinase inhibitors
08/22/2002WO2002064575A1 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1,3-oxazolins and the utilization thereof as anticoagulant and antithrombotic agents
08/22/2002WO2002064574A2 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
08/22/2002WO2002064572A1 Quinazolines as mmp-13 inhibitors
08/22/2002WO2002064571A1 Pyrimidine matrix metalloproteinase inhibitors
08/22/2002WO2002064568A1 Pyridine matrix metalloproteinase inhibitors
08/22/2002WO2002064565A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
08/22/2002WO2002064564A1 Benzo'f!isoindole derivatives with affinity to the ep4 receptor
08/22/2002WO2002064552A1 1g(a)-AMINO-N-HYDROXY-ACETAMIDE DERIVATIVES
08/22/2002WO2002064550A1 Glucocorticoid receptor modulators
08/22/2002WO2002064547A2 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
08/22/2002WO2002064546A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
08/22/2002WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals
08/22/2002WO2002064543A2 Novel succinate salt of o-desmethyl-venlafaxine
08/22/2002WO2002064169A1 Methods of treating diseases in association with decrease in the expression of aop-1 gene or aop-1 and remedies for the diseases
08/22/2002WO2002064160A2 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof
08/22/2002WO2002064159A1 Remedies for tumor in hematopoietic organs
08/22/2002WO2002064155A1 Pharmaceutical composition for prevention and remedy of osteoporosis
08/22/2002WO2002064146A1 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical
08/22/2002WO2002064138A1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester
08/22/2002WO2002064126A2 Method of treating of demyelinating diseases or conditions
08/22/2002WO2002064083A2 Synthesis of 3-amino-thalidomide and its enantiomers
08/22/2002WO2002064080A2 Matrix metalloproteinase inhibitors
08/22/2002WO2002045652A3 Tyrosine kinase inhibitors
08/22/2002WO2002042280A3 Pyrimidine derivatives
08/22/2002WO2002032377A3 Estrogen receptor modulators
08/22/2002WO2002002755A3 Regulation of human thimet oligopeptidase-like enzyme
08/22/2002WO2001074903A3 Cd20/ige-receptor like molecules and uses thereof
08/22/2002WO2000020449A9 MODIFIED TGF-β SUPERFAMILY PROTEINS
08/22/2002US20020115856 Selective cyclooxygenase-2 (COX-2) inhibitors; for example, 1-(5-Methanesulfonyl-pyridin-2-yl)-7-methoxy-3-trifluoromethyl-4,5-dihydro -1H-benzo(g)indazole
08/22/2002US20020115727 Synthesis, methods of using, and compositions of hydroxylated cyclobutylalkylamines
08/22/2002US20020115695 Combinations of a prostaglandin agonist and a HMG-CoA reductase inhibitor
08/22/2002US20020115684 2, 7-naphthyridine derivatives
08/22/2002US20020115676 Therapy for andropause using estrogen agonists / antagonists and testosterone
08/22/2002US20020115665 Contacting the calpain with an effective amount of an HIV protease inhibitor,
08/22/2002US20020115654 New compounds, their preparation and use
08/22/2002US20020115651 New hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation
08/22/2002US20020115639 Glucosamine and method of making glucosamine from microbial blomass
08/22/2002US20020115627 Phosphatonin-related gene and methods of use thereof
08/22/2002US20020115588 Dry powder of parathyroid hormone suitable for inhalation of specified particle size in diameters; treating osteoporosis
08/22/2002US20020115218 Gene delivery vectors with cell type specificity for primary human chondrocytes
08/22/2002US20020115156 Connective tissue growth factor for use in the treatment of cancer, fibrotic defects and atherosclerosis; for use as wound healing agents
08/22/2002US20020114848 Methods for regulating levels of zinc, cadmium and calcium in humans and for diagnosing, or screening for the risk of developing, diseases associated with abnormal levels of cadmium, zinc and calcium in body fluids and tissues
08/22/2002US20020114781 Interleukin antagonists for suppressing autoimmune respone via reducing number of antigen-reactive lymphocytes; treatment of rheumatic diseases
08/22/2002CA2666611A1 Novel succinate salt of o-desmethyl-venlafaxine
08/22/2002CA2440743A1 Matrix gene expression in chondrogenesis
08/22/2002CA2438712A1 Method of treating of demyelinating diseases or conditions
08/22/2002CA2438590A1 Therapeutic methods and agents for diseases associated with decreased expression of aop-1 gene or aop-1
08/22/2002CA2438501A1 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
08/22/2002CA2437643A1 Matrix metalloproteinase inhibitors
08/22/2002CA2437588A1 Triazolo compounds as mmp inhibitors
08/22/2002CA2437122A1 Quinazolines as mmp-13 inhibitors
08/22/2002CA2436371A1 Bicyclic pyrimidine matrix metalloproteinase inhibitors
08/22/2002CA2436195A1 Laulimalide derivatives
08/22/2002CA2435376A1 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
08/22/2002CA2434982A1 Pyridine matrix metalloproteinase inhibitors
08/22/2002CA2433843A1 Molecules for disease detection and treatment
08/22/2002CA2433778A1 Thieno'2,3-d pyrimidindione derivatives as matrix metalloproteinase inhibitors
08/22/2002CA2433075A1 Benzo thiadiazine matrix metalloproteinase inhibitors
08/22/2002CA2405532A1 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
08/21/2002EP1233023A1 Transcription factor and dna thereof
08/21/2002EP1233018A2 Tricyclic biphenyl sulfonamide matrix metalloproteinase inhibitors
08/21/2002EP1233017A1 Tricyclic sulfonamides useful as matrix metalloproteinase inhibitors
08/21/2002EP1233016A1 Biphenyl sulfonamides useful as matrix metalloproteinase inhibitors
08/21/2002EP1233013A1 Novel phenylalanine derivatives
08/21/2002EP1232757A1 Remedies for diseases in association with decrease in bone mass
08/21/2002EP1232748A1 Substituted nitrobenzene derivatives as medicines and other useful uses thereof
08/21/2002EP1232262A2 Recombinant gelatin in vaccines
08/21/2002EP1232183A2 Peptides having antiangiogenic activity
08/21/2002EP1232181A2 Recombinant gelatins
08/21/2002EP1232180A1 Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues
08/21/2002EP1232179A1 15 human secreted proteins
08/21/2002EP1232175A2 Method of forming a peptide-receptor complex with zsig33 and therapeutic use thereof
08/21/2002EP1232174A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals
08/21/2002EP1232155A1 Protease inhibitors
08/21/2002EP1232154A1 Protease inhibitors
08/21/2002EP1232150A1 Urea derivatives as anti-inflammatory agents
08/21/2002EP1232144A2 Novel il-8 receptor antagonists
08/21/2002EP1231983A2 Treatment of subnormal bone mineral density
08/21/2002EP1231982A2 Use of phthalazine derivatives
08/21/2002EP1231937A2 Tr3-specific binding agents and methods for their use
08/21/2002EP1231923A1 Protease inhibitors
08/21/2002EP1231922A1 Protease inhibitors
08/21/2002EP1231921A1 Protease inhibitors
1 ... 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 ... 820